These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7061693)

  • 1. Effect of endogenous opioid blockade on the amplitude and frequency of pulsatile luteinizing hormone secretion in normal men.
    Ellingboe J; Veldhuis JD; Mendelson JH; Kuehnle JC; Mello NK
    J Clin Endocrinol Metab; 1982 Apr; 54(4):854-7. PubMed ID: 7061693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous opiates modulate the pulsatile secretion of biologically active luteinizing hormone in man.
    Veldhuis JD; Rogol AD; Johnson ML
    J Clin Invest; 1983 Dec; 72(6):2031-40. PubMed ID: 6315775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endogenous opiates in the expression of negative feedback actions of androgen and estrogen on pulsatile properties of luteinizing hormone secretion in man.
    Veldhuis JD; Rogol AD; Samojlik E; Ertel NH
    J Clin Invest; 1984 Jul; 74(1):47-55. PubMed ID: 6429197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endogenous opiates in pubertal maturation: opposing actions of naltrexone in prepubertal and late pubertal boys.
    Mauras N; Veldhuis JD; Rogol AD
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1256-63. PubMed ID: 3517031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced frequency of pulsatile luteinizing hormone secretion in the luteal phase of the rhesus monkey. Involvement of endogenous opiates.
    Van Vugt DA; Lam NY; Ferin M
    Endocrinology; 1984 Sep; 115(3):1095-101. PubMed ID: 6745188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of endogenous opioid peptides in the initiation of the midcycle luteinizing hormone surge in normal cycling women.
    Rossmanith WG; Mortola JF; Yen SS
    J Clin Endocrinol Metab; 1988 Oct; 67(4):695-700. PubMed ID: 3138276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do alpha-adrenergic mechanisms regulate spontaneous or opiate-modulated pulsatile luteinizing hormone secretion in man?
    Veldhuis JD; Rogol AD; Williams FA; Johnson ML
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1292-6. PubMed ID: 6313736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsatile secretion of gonadotropins and prolactin in male marathon runners. Relation to the endogenous opiate system.
    Rogol AD; Veldhuis JD; Williams FA; Johnson ML
    J Androl; 1984; 5(1):21-7. PubMed ID: 6323369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of estradiol infusion and naloxone on luteinizing hormone secretion in pubertal boys.
    Kletter GB; Padmanabhan V; Beitins IZ; Marshall JC; Kelch RP; Foster CM
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4010-4. PubMed ID: 9398704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic opioid antagonism on the hypothalamic-pituitary-ovarian axis in hyperprolactinemic women.
    Matera C; Freda PU; Ferin M; Wardlaw SL
    J Clin Endocrinol Metab; 1995 Feb; 80(2):540-5. PubMed ID: 7852517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous opioid regulation of pulsatile luteinizing hormone secretion during sexual maturation in the female sheep.
    Ebling FJ; Schwartz ML; Foster DL
    Endocrinology; 1989 Jul; 125(1):369-83. PubMed ID: 2737153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting suppresses pulsatile luteinizing hormone (LH) secretion and enhances orderliness of LH release in young but not older men.
    Bergendahl M; Aloi JA; Iranmanesh A; Mulligan TM; Veldhuis JD
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1967-75. PubMed ID: 9626127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of pulsatile gonadotropin secretion by testosterone in man.
    Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 1984 Apr; 58(4):609-14. PubMed ID: 6421864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of short-term stimulation of serotoninergic pathways on the pulsatile secretion of luteinizing hormone in the absence and presence of acute opiate-receptor blockage.
    Urban RJ; Veldhuis JD
    J Androl; 1990; 11(3):227-32. PubMed ID: 2166728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of opioid antagonism with naltrexone on pulsatile luteinizing hormone secretion in women with hypothalamic amenorrhea in basal conditions and after discontinuation of treatment with pulsatile LHRH.
    Armeanu MC; Lambalk CB; Berkhout GM; Schoemaker J
    Gynecol Endocrinol; 1992 Mar; 6(1):3-12. PubMed ID: 1580165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for decreased luteinizing hormone-releasing hormone pulse frequency in men with selective elevations of follicle-stimulating hormone.
    Gross KM; Matsumoto AM; Southworth MB; Bremner WJ
    J Clin Endocrinol Metab; 1985 Jan; 60(1):197-202. PubMed ID: 3917266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous opioid peptides modulate the effect of corticotropin-releasing factor on gonadotropin release in the primate.
    Gindoff PR; Ferin M
    Endocrinology; 1987 Sep; 121(3):837-42. PubMed ID: 3113919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men.
    Pavlou SN; Veldhuis JD; Lindner J; Souza KH; Urban RJ; Rivier JE; Vale WW; Stallard DJ
    J Clin Endocrinol Metab; 1990 May; 70(5):1472-8. PubMed ID: 2110578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
    Baranowska B; Rozbicka G; Jeske W; Abdel-Fattah MH
    J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
    Couzinet B; Young J; Brailly S; Chanson P; Schaison G
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.